company insight

Enhancing patient safety is our mission

The success of a drug and its benefit to the patient or consumer is determined in the market. Why not use intelligence from the real world to prepare for the launch and to monitor and optimise its success? PHOENIX group is a leading integrated healthcare provider present in 27 European countries. Our real-world universe includes 150,000,000 patient contacts each year visiting our 2,500 own pharmacies, one of our 13,500 cooperation partners or one of the 56,000 pharmacies which are supplied with products through the wholesale channel.

PHOENIX Business Intelligence

Providing insights to make better bu siness decisions

PHOENIX Business Intelligence provides manufacturers with real-time real-world data helping to address key business issues like:

Optimisation of product portfolio, positioning and market access
Supply chain management ensuring product availability
Optimisation of promotional resources
Monitoring of product performance in real-time

150,000,000 patient contacts per year

PHOENIX is present in 27 European countries including its 164 distribution centres, 2,500 own pharmacies and 13,500 pharmacy cooperation partners. For the largest markets a harmonised dataset is loaded into one database with daily synchronization, and more and more countries are rolling onto it. Pharmaceutical manufacturers can benefit from this real world and real time database in many ways.

PHOENIX Commercial Partnerships

Providing sales growth on European, regional and local level through proven business services.

Incremental growth opportunities for our partners
Proven business models capturing incremental opportunities
Common progress towards a joint goal – maximising patient outcome
Preferred access to our value added All-in-One services, such as Patient Services, Business Intelligence, Sales Support, Supply Chain Optimisation, and many more

Our main goals:

Growing sales
Maintaining sales
Slowing down decrease

PHOENIX Clinical Trial Supply Services

A highly specialised provider of solutions within clinical trial supply

With more than 30 years of experience, we have the expertise, the best services and the flexibility to help you achieve the optimal clinical trial supply and add knowledge and success to your clinical Trials.

As a full-line wholesaler, we collaborate with most pharmaceutical manufacturers to deliver medicine to the patients and develop new logistics concepts, therefore, we have direct access to all necessary supplements and are the ideal partner to also take care of your comparator sourcing.

Today we are working with clinical trials ranging from small biotech to large pharma sponsored trials and investigator initiated studies.

We create optimal individualised solutions by adjusting and combining our services according to the specific needs of our clients. Our highly flexible solutions range from clinical trial supply planning and optimisation, production of labels, GMP packaging, global distribution and return, and destruction. The aim is to ensure the most effective logistics setup and optimal clinical trial supply management for local and global clinical trials.

Benefit from our high quality solutions with secure, validated, controlled and audit proven processes
Our deep local knowledge and global coverage will add success to your clinical trial
Being specialist in Clinical Trial Logistics, we are your reliable partner with our expertise in cold chain, narcotics and special products

PHOENIX Healthcare Logistics

What is Healthcare Logistics?

Regional Approach/ Cluster: Nordics/ Baltics, Benelux, CEE, Non-EU BMS
Ease of doing business and joint development with one service provider – better results with less administration
Market access and good market knowledge to support your sales
Joint evaluation of supply chain for the best solution for your products
Optimising stock levels for reduced NWC
Assuring high service levels to fulfill sales targets
Ensuring high quality and transparency throughout the chain for increased control
Additional commercial and pharmaceutical services for improving cost efficiency while developing top line growth
Full logistic services in all product groups with over 40 DC's in 23 countries, a capacity for over 300,000 pallets and serving more than 200 manufacturers

PHOENIX Patient Services

Helping you to improve patient adherence and outcomes

Pharmaceutical companies face a yearly revenue loss due to patient non-adherence of more than $500 billion per year.
PHOENIX has proven to be able to develop, implement and deliver Patient Services through our large pharmacy network of more than 16,000 owned and cooperative pharmacies that generate increased adherence and better outcomes, thus generating incremental business.

PHOENIX Sal es Support

PHOENIX has a deep market knowledge in 27 countries across Europe and can help you get access to the right market, from initial market research, product registration and product launches.
With our dedicated field force and our strong relationships with stakeholders in the markets, we support you in the regulatory affairs as well as in executing marketing campaigns.

PHOENIX Specialty

PHOENIX is your partner for your high-value Specialty products.

With our Pan-European coverage and our various service offerings we help you get closer to your patients and offer a cost-efficient supply-chain for your high-value products.

Pan-European tailor made logistics setup, combining, pre-wholesale, wholesale as well as DTH/DTP solutions
High-quality distribution centers, fulfilling your high quality standards
Full transparency and control of the product-flow along the whole supply-chain
Direct access to pharmacies, hospitals, doctors and patients’ home
Valuable insights with our Business Intelligence offerings
Patient centricity via our Patient Services offerings

PHOENIX Supply Chain Optimisation

Project targets:

Optimising cost of capital by reducing goods on stock
Improving product availability
Optimising processes and improving efficiency
Increase productivity in goods handling
Decrease administrative effort
Gaining competitive advantages by improved availability and faster goods flow

For more information contact us:

PHOENIX group Corporate Pharma Services

PHOENIX Pharmahandel GmbH & Co KG

Pfingstweidstraße 10-12

68199 Mannheim, Germany

www.phoenix-all-in-one.eu

Go to top

Share this article

02/24/2024 04:24:44

Enhancing patient safety is our mission

The success of a drug and its benefit to the patient or consumer is determined in the market. Why not use intelligence from the real world to prepare for the launch and to monitor and optimise its success? PHOENIX group is a leading integrated healthcare provider present in 27 European countries. Our real-world universe includes 150,000,000 patient contacts each year visiting our 2,500 own pharmacies, one of our 13,500 cooperation partners or one of the 56,000 pharmacies which are supplied with products through the wholesale channel.

On 9^th February 2019 the European Falsified Medicines Directive (FMD) is going into effect. The aim of FMD is to combat the entry of falsified medicines in the legitimate pharmaceutical supply chain. The FMD requires the placement of safety features consisting of a unique identifier and an anti-tampering device on the packaging of certain prescribed medicinal products for human use for the purposes of allowing their identification and authentication.

The PHOENIX group as trusted and quality-oriented healthcare provider in 27 European countries takes the topic of Falsified Medicines Directive very seriously. Several business segments are impacted: retail, wholesale, healthcare logistics (pre-wholesale) and GMP services, such as repackaging. The implementation of FMD across the different business segments in the various countries is progressing well and PHOENIX will be ready and FMD-compliant by 9^th February 2019.

Especially patient safety is of paramount importance to PHOENIX and that's why our engagement is an essential step forward to ensure the safety of medicines that reach patients - in every market! That's why we have been working diligently and pro-actively on the implementation of the EU Falsified Medicines Directive across all of our business areas to be fully compliant to the legislation in all impacted markets. PHOENIX is constantly involved in the implementation process together with the other supply chain panners and their representative bodies at both national and European levels. In this respect, PHOENIX has collaborated and still actively collaborating actively with the European Healthcare Distribution Association (GIRP), which functions as the umbrella organisation for pharmaceutical full line wholesalers in Europe, and of which PHOENIX is a full member company.

In addition to the technological aspects of the FMD implementation, PHOENIX countries are investing a lot of effort locally in dispensing appropriate education and training to their employees, in order to make the transition into the FMD era as seamless as possible, which by extension, implies better service to our end customers, in line with our patient-centric approach.

More information:

www.phoenix-all-in-one.eu

02/24/2024 04:24:45